Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Type I Hepatorenal Syndrome (HRS) With Pentoxyfylline: A Placebo Controlled, Blinded Pilot Study

NCT02123576 is registered in ClinicalTrials.gov with Patrick Northup, MD as lead sponsor.

NCT NCT02123576
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02123576 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Type I Hepatorenal Syndrome (HRS) With Pentoxyfylline: A Placebo Controlled, Blinded Pilot Study
Lead sponsor
Patrick Northup, MD
Phase
Not applicable
Overall status
Terminated
Start date
April 30, 2014
Completion date
December 31, 2017
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatorenal syndrome